UK Markets open in 7 hrs 1 min

AgeX Therapeutics, Inc. (AGE)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.7667-0.0011 (-0.14%)
At close: 04:00PM EST
Currency in USD

Valuation measures

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.0600
52-week low 30.7100
50-day moving average 30.8740
200-day moving average 31.3393

Share statistics

Avg vol (3-month) 378.08k
Avg vol (10-day) 3119.85k
Shares outstanding 537.94M
Implied shares outstanding 6N/A
Float 818.45M
% held by insiders 143.45%
% held by institutions 118.50%
Shares short (14 Jul 2021) 4669.77k
Short ratio (14 Jul 2021) 49.23
Short % of float (14 Jul 2021) 43.12%
Short % of shares outstanding (14 Jul 2021) 41.77%
Shares short (prior month 14 Jun 2021) 4623.41k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 215:16
Last split date 305 May 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-542.56%

Management effectiveness

Return on assets (ttm)-150.81%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.83M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-37.10%
Gross profit (ttm)1.71M
EBITDA -8.82M
Net income avi to common (ttm)-9.82M
Diluted EPS (ttm)-0.2880
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)809k
Total cash per share (mrq)0.02
Total debt (mrq)7.35M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.55
Book value per share (mrq)-0.14

Cash flow statement

Operating cash flow (ttm)-8.38M
Levered free cash flow (ttm)-4.86M